The clinical course of AQP4‐IgG‐positive NMOSD is characterized by recurrent episodes of acute optic neuritis (ON), acute myelitis, or area postrema syndromes (APS) (Wingerchuk et al., 2015). This evidence concerns the gene AQP4 and autoimmune polyendocrinopathy.